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Background: The macrolide antibiotic erythromycin A, like other complex
aliphatic polyketides, is synthesised by a bacterial modular polyketide synthase
(PKS). Such PKSs, in contrast to other fatty acid and polyketide synthases
which work iteratively, contain a separate set or module of enzyme activities for
each successive cycle of polyketide chain extension, and the number and type
of modules together determine the structure of the polyketide product. Thus,
the six extension modules of the erythromycin PKS (DEBS) together catalyse
the production of the specific heptaketide 6-deoxyerythronolide B.
Results: A mutant strain of the erythromycin producer Saccharopolyspora
erythraea, which accumulates the aglycone intermediate erythronolide B, was
found unexpectedly to produce two novel octaketides, both 16-membered
macrolides. These compounds were detectable in fermentation broths of
wild-type S. erythraea, but not in a strain from which the DEBS genes had been
specifically deleted. From their structures, both of these octaketides appear to
be aberrant products of DEBS in which module 4 has ‘stuttered’, that is, has
catalysed two successive cycles of chain extension.
Conclusions: The isolation of novel DEBS-derived octaketides provides the first
evidence that an extension module in a modular PKS has the potential to catalyse
iterative rounds of chain elongation like other type I FAS and PKS systems. The
factors governing the extent of such ‘stuttering’ remain to be determined.
Introduction
Fatty acid synthases (FASs) provide the paradigm of a
multienzyme system that sequentially adds units to a
growing chain by the repeated operation of a single set of
enzyme active sites, before release of the final product.
Although the protein architecture of FAS multienzymes
varies from the multifunctional polypeptides (type I
systems) in fungi and animals [1], to the dissociable mono-
functional enzymes (type II systems) of most bacteria [2],
the mechanism of iterative chain extension is essentially
the same. Similarly, the type II polyketide synthases
(PKSs) that catalyse the production of aromatic polyke-
tides in bacteria do so by simple, repetitive use of a core
set of FAS-related enzyme activities [3]. Fungal type I
PKSs, as first shown for 6-methylsalicylic acid synthase
(MSAS) of Penicillium patulum [4], also contain a single set
of enzymes, even though (by mechanisms that are not yet
understood) the degree of reduction accomplished during
each successive cycle may be different. 
In contrast, complex macrocyclic polyketides such as the
antibacterial erythromycin A 1 and the immunosuppressant
rapamycin are synthesised, in Streptomyces and related bac-
teria, on modular type I PKS assemblies, in which a differ-
ent set or module of enzymes is used to catalyse each
successive cycle of chain extension [5,6]. Thus, the polyke-
tide synthase responsible for production of the aglycone
6-deoxyerythronolide B (6-dEB) 2 catalyses the decar-
boxylative condensation of six (2S)-methylmalonyl-CoA
extender units [7] with a propionate starter unit derived
from propionyl-CoA. The 6-dEB synthase (DEBS) consists
of three multifunctional proteins (DEBS1, DEBS2 and
DEBS3) [8], each of which houses two extension modules
(Figure 1a), although in other systems the number of
modules in a single protein may vary from one [9] to six
[10,11]. This linear, processive mechanism appears to be
general for the biosynthesis of aliphatic polyketides by type
I PKSs in bacterial systems [5,6,12–19], as well as for nonri-
bosomal peptide biosynthesis [20]. For DEBS, the loading
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Figure 1
(a) The erythromycin-producing PKS; primary organisation of the
genes and their corresponding protein domains. There are six chain
extension modules each beginning with a β-ketoacyl synthase domain
that are responsible for adding the six successive extension units. The
completed chain is released as a heptaketide macrolactone by the
thioesterase domain. AT, acyltransferase; ACP, acyl carrier protein; KS,
β-ketoacyl synthase; KR, β-ketoacyl reductase; DH, dehydratase; ER,
enolyreductase; TE, thioesterase. (b) The post-PKS modifications of
6-dEB (2) which give rise to erythromycin A (1) in the S. erytharaea
NRRL2338 wild-type parental strain.
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module (the acyl transferase–acyl carrier protein (AT–ACP)
bidomain at the amino terminus of DEBS 1) [21] and the
six extension modules together produce an enzyme-bound
heptaketide chain, which is subsequently cyclised to the
first enzyme free intermediate 6-dEB 2 through the action
of a thioesterase domain (TE) at the carboxyl terminus of
DEBS 3. Several post-PKS steps, including hydroxylation,
glycosylation and methylation, finally yield the active
antibiotic 1 (Figure 1b) [22].
The chain length of the polyketide product of DEBS has
been altered to generate diketide [23], triketide [24],
tetraketide [25] and hexaketide [26] products. In these
experiments, the terminating thioesterase was re-located
to the end of a PKS gene assembly containing the requi-
site number of extension modules, whereas in other work
combinations of modules have been assembled to yield
specific polyketide products [27,28]. The products formed
by both natural and engineered PKSs have thereby been
shown to be dictated by the number and type of modules
in the PKS responsible. In a few cases, a ‘shorter’ polyke-
tide product has been observed [13,29] and attributed to
premature release of the growing chain during the exten-
sion process. However, bacterial modular type I PKSs have
never been reported to produce longer products, through
the iterative use of one or more extension module(s).
As part of our work aimed at the production of novel
polyketide metabolites through engineered (combinator-
ial) biosynthesis [22,30–33], a detailed chromatographic
characterisation has been performed of the fermentation
products produced both by an erythromycin-producing
strain of Saccharopolyspora erythraea and also by mutants of
S. erythraea specifically deficient in either 6-dEB produc-
tion or in glycosylation of the macrolide aglycone. Such
S. erythraea strains, in conjunction with the recently-
described Escherichia coli /Streptomyces shuttle vector
pCJR24 [34], provide useful hosts for heterologous expres-
sion of hybrid PKSs. Particular attention was paid to iden-
tifying minor compounds which are often formed as shunt
products of biosynthetic pathways. In this way two new
octaketide macrolides have been identified and charac-
terised as products of a mutant of S. erythraea NRRL2338,
and have then been detected in the wild-type strain. The
structures of these new products indicate that module 4 of
the DEBS multienzyme is capable of catalysing two (itera-
tive) rounds of chain elongation, a phenomenon we refer
to as ‘stuttering’. 
Results
Two novel 16-membered macrolides from S. erythraea
The mutant S. erythraea strain number 5 (whose construc-
tion will be described elsewhere) specifically lacks the
ability to convert erythronolide B into later metabolites
in the erythromycin biosynthetic pathway. The mutant
S. erythraea strain JC2 lacks the eryAI-AIII genes that
govern production of DEBS, and it therefore produces no
erythromycins, but retains, functionally intact, all the
genes responsible for post-PKS modification of 2 to 1
[34]. The fermentation of these strains, and of the wild-
type erythromycin-producing strain, was performed in
two stages, a seed stage (SV2 medium), followed by a
production stage (SM3 medium). Methanol extracts of
whole broth and ethyl acetate extracts of culture super-
natants were subjected to liquid chromatography–mass
spectroscopy (LC–MS) analysis using both electrospray
(ES) and atmospheric-pressure chemical-ionisation
(AP–CI) techniques.
The analysis of extracts from the fermentation of S. ery-
thraea number 5 showed the presence of significant
amounts of several unknown species, albeit at low levels
when compared with 6-dEB 2 or EB 3. Further analysis of
two such components, eluting close together and with
parent masses of 414 and 428 revealed distinctive
LC–MS–MS spectra [35] indicative of polyketide macrolide
products derived from acetate and propionate starter units,
respectively. The ability of the DEBS1 loading bidomain to
accept both propionate and acetate starter units has been
well documented [36].
The two unknown compounds were extracted from a 3 l
fermentation of S. erythraea number 5, and shown, using
LC–MS, to represent about 1% of the amounts of 2 and 3
present. The two compounds were isolated after repeated
rounds of preparative-scale reverse-phase high-perfor-
mance liquid chromatography (HPLC), but in low yields
(0.5–1 mg each). The combined titer of 2 and 3 from a
typical fermentation was approximately 50 mg/l.
The molecular weights of the two new compounds 5 and 6
(Figure 2) were obtained using LC–ES–MS, and the mol-
ecular formulae determined from high-resolution 
ES–TOF–MS data. Their structural analysis was com-
pleted using one-dimensional and two-dimensional nuclear
magnetic resonance (NMR) spectroscopic methods, with
the long range 1H–13C correlations from the regularly
spaced methyl groups being most helpful. To our surprise
the data readily identified 5 and 6 as octaketides, both of
them being 16-membered macrolides. These structures are
clearly related to that of 6-dEB 2, except that the normal
fourth extension cycle seems to have been repeated. 
Proposed mechanism for formation of octaketide
16-membered macrolides by ‘stuttering’ on the DEBS
multienzyme
It has been shown previously that a suitably function-
alised synthetic triketide can be recognised as a diketide
analogue by DEBS and elongated to an octaketide [37].
However, the de novo biosynthesis of an octaketide by a
native hexamodular PKS, as observed here, is unprece-
dented. The structures of the observed octaketides
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immediately suggested that the octaketides might repre-
sent aberrant products of the DEBS PKS, where the PKS
had ‘stuttered’ at the end of DEBS module 4, that is, had
catalysed an additional (iterative) round of chain elonga-
tion before transfer of the chain to module 5 in DEBS3
(Figure 3). Formation of 5 and 6 must be catalysed by
DEBS module 4, because module 4 is the only module in
DEBS that carries the full complement of reductive
domains required for the formation of a methylene group.
This homologation reaction would require the normal
pentaketide product of module 4, attached to the ACP, to
be transferred onto the active-site cysteine residue within
the β-keto acyl synthase (KS) domain of the same
module. A second module-4-catalysed chain extension
event would then occur, producing a hexaketide chain
attached to the ACP of module 4, which would then be
transferred to the KS of module 5 (Figure 3).
On the basis of a proposed helical structure of DEBS [38],
we can attempt to describe the movement of the stuttering
chain within module 4. This helical model for DEBS is the
only one in accordance with all the published structural and
mechanistic data available [38–41]. The helical model pre-
dicts a structure for DEBS2 (Figure 4) in which a DEBS2
homodimer has modules associated head-to-head and tail-
to-tail that twist together to form a rope-like quaternary
structure. The core KS, AT and ACP domains are associated
along the axis of the structure with the reductive domains
present as loops to the sides. One clear indication from this
model is that the KS4 domain of one chain can interact only
with ACP4 of the opposite chain. This is in agreement with
data from chemical-cross-linking and proteolysis studies
[38,39] and from mutant complementation [40,41]. Thus, in
order to perform the second chain extension event, and sub-
sequent reduction to a methylene group, the ‘stuttering’
chain must be passed back to the same KS4 domain that
catalysed the initial chain extension event. As such, chain
elongation during ‘stuttering’ is truly iterative.
It cannot be ruled out that other minor metabolites, which
correspond to iterative use of one of the other five DEBS
modules, are produced even though they were not
detected in our experiments. The isolation of the particular
compounds 5 and 6 may, for example, reflect higher yields
114 Chemistry & Biology 2000, Vol 7 No 2
Figure 2
The compounds 5 and 6, which we believe occur when module 4 of
DEBS2 catalyses an additional iterative round of chain elongation. The
absolute stereochemistries are inferred from that of 6-dEB 2.
Figure 3
The normal pentaketide product of module 4 can either process the
growing chain to the KS domain of module 5 (a) in the normal manner
to produce after two further rounds 6-dEB 2, or it can reacylate the KS
domain of module 4 (b), which then undergoes a second chain
extension event on this module (c) before processing the new
hexaketide to module 5 thereby giving rise to the iterative product 6
through ‘stuttering’ of DEBS.
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arising from the position of module 4 at the end of a PKS
multienzyme, where stuttering may compete more effec-
tively with intermodular transfer between different DEBS
multienzymes, than elsewhere in DEBS with intraprotein
transfers between modules.
Octaketides are not produced by mutant S. erythraea
lacking the DEBS genes
An alternative possibility for the origin of 5 and 6 could be
the presence of a second PKS gene cluster in S. erythraea
that is closely related to DEBS but has an additional
(seventh) extension module. Such a PKS has not been
identified following the careful analysis of total genomic
DNA from this strain using PKS-specific hybridisation
probes, but as a direct check we examined the fermenta-
tion supernatant of the S. erythraea mutant strain JC2 [34].
In this mutant the genes for almost the entire DEBS PKS
have been specifically removed. After the LC–MS analy-
sis of extracts from 24 individual S. erythraea JC2 single
colonies, each fermented in two different media (complex
and defined), no compounds corresponding to 5 and 6
could be observed. The data were verified by spiking each
of the extracts with solutions of authentic 5 and 6. When
these experiments were repeated in the presence of added
6-dEB 2, both 5 and 6 remained undetectable, whereas 2
was readily converted to 1, demonstrating that a later
intermediate in erythromycin biosynthesis is not an essen-
tial trigger for formation of 5 and 6.
The failure to detect 5 and 6 in these experiments was
shown to be significant using S. erythraea mutant strain
number 5, in which the DEBS genes are intact, but in which
aglycone processing is deficient. Of 24 parallel fermenta-
tions of single colony isolates of the number 5 mutant, 14 of
the clones produced 5 and 6 at levels similar to that which
had led to their isolation, whereas several others produced
them at reduced levels. These data taken together clearly
implicate the DEBS proteins in the biosynthesis of 5 and 6.
The analysis of 24 single colony fermentations of wild-
type S. erythraea showed even lower levels of the two new
compounds as judged using LC–MS. However, in over
half of these we were able to identify 5 and 6 using
LC–MS techniques, and confirmed that they co-eluted
with authentic materials. The lower levels observed in fer-
mentations of the wild-type strain may be a consequence
of the presence of the full complement of aglycone-modi-
fying enzymes. Some preliminary evidence (data not
shown) was obtained, using LC–MS, for a species in which
6 may have been modified by hydroxylation and addition
of a mycarosyl moiety (cf. compound 4, Figure 1b).
Determination of chain length on modular PKS
multienzymes
The results reported here demonstrate an apparent break-
down of ‘co-linearity’ between the number and type of
modules in a type I modular PKS, and the chain length of
the polyketide product. Previously reported experiments,
in which hybrid polyketide products were obtained from
engineered modular PKSs, have already shown that these
systems can sometimes tolerate significant changes in sub-
strate structure. Repeated chain extension upon a particu-
lar module, analogous to that observed for FASs and
fungal PKSs [42,43], can therefore be viewed simply as
another consequence of such imperfect molecular recogni-
tion. Indeed, the observation of stuttering emphasises that
there is no fundamental mechanistic difference between
modular type I PKS and iterative PKSs and FASs.
Modular PKSs have presumably evolved to minimise stut-
tering, by ensuring that the KS domain of each extension
module, vacated after the condensation step, is rapidly
occupied by an incoming acyl chain so that the newly
extended acyl chain (which after condensation is attached
to the ACP) is prevented from migrating back to the KS
domain of the same module. This view of catalysis on
modular PKSs would imply the simultaneous extension of
multiple chains on the PKS, which is in accord with recent
experiments where blocking the transfer of the completed
polyketide chain from the rifamycin PKS apparently leads
to shedding of partially assembled polyketides of different
length from every extension module [44].
Significance
Modular polyketide synthases (PKSs) normally exert a
rigorous control over chain length, because each exten-
sion module in the multienzyme assembly line operates
only once before handing on the extended polyketide
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Figure 4
Three-dimensional representation of DEBS2 based on the proposed
helical model [38]. The domains are shown as spheres, and the two
chains of the homodimer are coloured differently. The arrows show the
movement a processing polyketide chain would take along DEBS2,
which clearly shows that the KS and AT domains of opposite chains of
the synthase must co-operate with one another, and not with those of
the same chain.
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chain, and a thioesterase or other transferase precisely
controls release of the full-length product. Similarly, trun-
cated products are readily rationalised as the products of
premature termination and release. However, we have
shown here, for the hexamodular 6-deoxyerythronolide B
(6-dEB) synthase (DEBS) from the erythromycin
biosynthetic pathway, that low levels of octaketide prod-
ucts are also formed. The structures of these 16-mem-
bered lactones, when compared with those of the normal
14-membered lactones produced by this PKS, indicate
that module 4 of DEBS has aberrantly operated twice in
succession, a phenomenon we refer to as ‘stuttering’.
This unexpected observation underlines the close mecha-
nistic connection between the modular PKSs and the
wholly iterative fatty acid synthases and fungal PKSs,
and provides additional insight into the mechanisms by
which the modular PKS ensures fidelity of chain exten-
sion.
Materials and methods
Chemical analysis
NMR spectra were obtained using standard pulse sequences on a Bruker
AMX 500 spectrometer fitted with a 3 mm Nalorac broad band probe.
LC-MS analysis was performed on a Finnegan MAT LCQ–MS coupled to
a Hewlett Packard 1050 HPLC integrated system. Analyses were run
using either an ES or AP–CI interface and using positive–negative ionisa-
tion mode switching. Chromatography was over a 5 micron Hypersil C18
BDS column (150 mm × 4.6 mm i.d.) eluting at 1 ml/min with a gradient of
0–100%B over 30 min (A = 10 mM ammonium acetate + 0.1% formic
acid; B = 90%-acetonitrile:10%-10 mM ammonium acetate). Accurate
mass data were obtained using a Micromass QTOF fitted with an ES
source operated in the positive ion mode. The instrument was calibrated
using a polyethylene glycol mixture (200/400/600/1000) with corrections
for drift made with a lock mass of erythromycin A.
Fermentation and extraction
S. erythraea NRRL2338 and the mutant S. erythraea strains JC2 and
No.5 were maintained on plates of R2T20 agar at 30°C. Spores were
harvested after ~2 weeks and stored in 10% glycerol at –80°C (spores
from one plate were resuspended in 2 ml). Frozen spore suspension
(100 µl) was used to inoculate 50 ml of SV2 seed medium in a 250 ml
conical flask. SV2 medium contained per litre of deionised water:
glucose (15 g), glycerol (15 g), soy peptone (15 g), NaCl (3 g) and
CaCO3 (1 g); adjusted to pH 7.0 before autoclaving. The seed culture
was incubated at 250 rpm and 28°C for 3 days. This was then used to
inoculate SM3 production medium (2% v/v) which was incubated at
28°C and 250 rpm. SM3 medium contained per litre of deionised
water: glucose (5 g), maltodextrin (glucidex; 50 g), soya flour (arkasoy;
25 g), beet molasses (3 g), K2HPO4 (0.25 g), CaCO3 (2.5 g); adjusted
to pH 7.0 before autoclaving. Larger-scale fermentations were carried
out in 2 l Florence flasks containing 300 ml of SM3 medium. After
7 days the fermentation broths were harvested by centrifugation and
the supernatant extracted with an equal volume of ethyl acetate con-
taining ethanol (0.5% v/v.) This was repeated twice, and solvents were
removed from the combined extracts in vacuo to yield a viscous red oil.
Analytical scale fermentations were carried out in the same way in
miniature culture vessels containing 7 ml of SV2, SM3 or sucrose-suc-
cinate defined medium [24]. The oily residues from analytical fermenta-
tions were redissolved in methanol (100 µl), an equal volume of water
was added and the mixture was then centrifuged to remove particulate
matter before the supernatant (10 µl) was analysed using LC–MS.
Isolation and purification of metabolites
The extract from 3 l of S. erythraea NRRL2338/no.5 fermentation broth
(960 mg) was resuspended in a mixture of 1:1 methanol/water (6 ml)
and filtered. The resulting solution was subjected to preparative HPLC-
MS (Gilson 305/306 pumps, 811C mixer and 806 manometric module)
(4 × 1.5 ml injections) using a 5 micron Hypersil Elite C18 column
(150 mm × 21.2 mm i.d.) eluted at 15 ml/min with a gradient of 0–100%
solvent B over 75 mins, then held at 100% solvent B for 15 mins.
Solvent A: milli-Q water plus 10 ml/litre 1 M ammonium acetate; Solvent
B: 80% acetonitrile/water plus 20 ml/litre 1 M ammonium acetate. Frac-
tions were collected every minute and the eluate was monitored at
220 nm, then split (1:400 ratio) for ES-MS analysis (Micromass LCZ
platform.) The combined fractions containing 5 and 6 respectively were
concentrated on Bond Elute 500 mg C18 cartridges. After washing with
water, 5 and 6 were eluted with methanol, which was then removed in
vacuo and the residues (ca. 10 mg) were dissolved in acetonitrile
(0.5 ml). These fractions were further purified (4 × 125 µl injections) by
HPLC on a 5 micron Hypersil BDS C18 column (150 mm × 4.6 mm i.d.)
eluted with 70% acetonitrile/water containing 15 ml/litre 1 M ammonium
acetete and monitored at 220 nm. The fractions were analysed by flow-
injected ES-MS, and those fractions containing 5 or 6 respectively were
combined and concentrated using Bond Elute 500 mg C18 cartridges,
which were washed with water. After elution with methanol, which was
then removed in vacuo, ~0.5 mg each of 5 and 6 was obtained.
GW479439x (5)
1H NMR (500 MHz, d6-DMSO) δ = 5.34 (dq, 1H, J = 6.5 & 1.0, 15-H),
4.80 (d, 1H, J = 6.0, 3-OH), 4.57 (d, 1H, J = 7.5, 13-OH), 4.05 (d, 1H,
J = 5.0, 5-OH), 3.88 (ddd, 1H, J = 10.0, 7.5 & 2.5, 13-H), 3.54 (ddd,
1H, J = 8.5, 6.0 & 2.0, 3-H), 3.46 (ddd, 1H, J = 6.5, 5.0 & 2.5, 5-H),
2.90 (m, 10-H), 2.76 (dq, 1H, J = 7.0 & 2.5, 12-H), 2.51 (1H, 2-H),
1.60 (1H, 6-H), 1.57 (1H, 4-H), 1.53 (1H, 14-H), 1.47 (1H, 7-H), 1.40
(1H, 9-H), 1.19 (d, 3H, J = 6.5, 16-H), 1.12 (d, 3H, J = 7.0, 18-H),
1.01 (1H, 9-H), 0.96 (d, 3H, J = 6.5, 20-H), 0.95 (d, 3H, J = 7.0,
19-H), 0.95 (d, 3H, J = 7.0, 22-H), 0.91 (1H, 7-H), 0.88 (d, 3H,
J = 7.0, 21-H), 0.88 (d, 3H, J = 7.0, 24-H), 0.87 (d, 3H, J = 7.0, 23-H).
13C NMR (100 MHz, d6-DMSO) 214.8 (C-11), 175.1 (C-1), 76.3
(C-5), 74.7 (C-3), 70.8 (C-13), 69.0 (C-15), 45.2 (C-12), 43.5 (C-2),
43.1 (C-9), 41.9 (C-14), 39.8 (C-4), 38.9 (C-10), 37.4 (C-7), 36.5
(C-6), 28.9 (C-8), 22.9 (C-21), 18.7 (C-20), 18.7 (C-16), 15.8 (C-22),
14.7 (C-17), 9.1 (C-24), 8.4 (C-19), 6.8 (C-23).
MS (ES-TOF) m/z C23H43O6 calc’d 415.3060, found 415.3072
[MH]+. C23H42O6Na calc’d 437.2879, found 437.2896 [MNa]+.
GW479438x (6)
1H NMR (500 MHz, d6-DMSO) δ = 5.17 (dd, 1H, J = 4.5 & 9.5, 15-H),
4.82 (brs, 1H, 3-OH), 4.50 (d, 1H, J = 7.0, 13-OH), 4.03 (brd, 1H,
J = 4.5, 5-OH), 3.86 (ddd, 1H, J = 2.5, 7.0 & 10.0, 13-H), 3.52
(brd, 1H, J = 9.5, 3-H), 3.48 (brs, 1H, 5-H), 2.86 (m, 1H, 10-H), 2.74
(dq, 1H, J = 2.5 & 6.5, H-12), 2.56 (dq, 1H, J = 9.5 & 6.5, 2-H), 1.68
(1H, 16-H), 1.59 (1H, 14-H), 1.55 (1H, 6-H), 1.54 (1H, 4-H), 1.47
(1H, 8-H), 1.46 (1H, 16-H), 1.44 (1H, H-7), 1.38 (1H, H-9), 1.15
(d, 3H, J = 6.5, 18-H), 1.00 (1H, H-9), 0.97 (d, 3H, J = 7.0, H-20),
0.95 (d, 3H, J = 6.5, H-22), 0.94 (d, 3H, 7.0, H-19), 0.91 (1H, H-7),
0.88 (d, 3H, J = 6.5, H-21), 0.86 (d, 3H, J = 6.5, H-23), 0.84 (d, 3H,
J = 7.0, H-24), 0.84 (t, 3H, J = 7.5, H-17).
13C NMR (100 MHz, d6-DMSO) δ = 213.5 (C-11), 175.5 (C-1), 76.2
(C-5), 74.8 (C-3), 74.5 (C-15), 71.0 (C-13), 45.3 (C-12), 43.5 (C-2),
43.3 (C-9), 40.6 (C-14), 39.8 (C-4), 38.8 (C-10), 37.2 (C-7), 36.9
(C-6), 29.1 (C-8), 25.9 (C-16), 22.9 (C-21), 18.7 (C-20), 15.9 (C-22),
15.5 (C-18), 9.8 (C-17), 9.5 (C-24), 8.4 (C-19), 6.7 (C-23).
MS (ES-TOF) m/z C24H44O6Na calc’d 451.3036, found 451.3020
[MNa]+. C24H48NO6 calc’d 446.3482, found 446.3469 [MNH4]+.
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